We are live on ! Find out more
Morgan Stanley

Morgan Stanley Portfolio holdings

AUM $1.66T
1-Year Est. Return 25.57%
 

Morgan Stanley, founded in 1935 by Henry Sturgis Morgan and Harold Stanley as a spin-off from J.P. Morgan & Co., is a leading global financial services firm headquartered in New York City. Initially focused on investment banking, it has evolved into a diversified powerhouse offering wealth management, institutional securities, and asset management services, catering to corporations, governments, institutions, and high-net-worth individuals. With a strong presence in mergers and acquisitions, underwriting, and trading, Morgan Stanley manages billions in assets and is known for its sophisticated financial advisory services. The firm has adapted to modern markets by expanding its digital offerings and wealth management division, notably through its 2020 acquisition of E*TRADE, solidifying its position as a Wall Street titan.

This Fund
S&P 500
This Quarter Est. Return
+28.45%
1 Year Est. Return
+25.57%
3 Year Est. Return
+85.95%
5 Year Est. Return
+96.01%
10 Year Est. Return
+409.32%
AUM
$452B
AUM Growth
+$83.8B
Cap. Flow
-$1.84B
Cap. Flow %
-0.41%
Top 10 Hldgs %
16.9%
Holding
6,941
New
185
Increased
3,288
Reduced
2,645
Closed
222

Sector Composition

Rank Sector Weight
1 Technology 19.32%
2 Healthcare 10.4%
3 Consumer Discretionary 8.1%
4 Communication Services 7.82%
5 Financials 7.44%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
DMAC icon
5576
DiaMedica Therapeutics
DMAC
$342M
$41K ﹤0.01%
+5,800
New +$25.9K
NUMG icon
5577
Nuveen ESG Mid-Cap Growth ETF
NUMG
$350M
$41K ﹤0.01%
1,048
-55
-5% -$1.94K
NUMV icon
5578
Nuveen ESG Mid-Cap Value ETF
NUMV
$444M
$41K ﹤0.01%
1,687
VHI icon
5579
Valhi
VHI
$380M
$41K ﹤0.01%
3,858
+2,734
+243% +$29.1K
YOLO icon
5580
AdvisorShares Pure Cannabis ETF
YOLO
$29.8M
$41K ﹤0.01%
4,042
-200
-5% -$1.9K
ONIT
5581
Onity Group
ONIT
$309M
$41K ﹤0.01%
4,176
-36,882
-90% -$317K
GRTX
5582
DELISTED
Galera Therapeutics, Inc. Common Stock
GRTX
$41K ﹤0.01%
5,793
+1,046
+22% +$11.1K
DSE
5583
DELISTED
Duff & Phelps Select MLP and Midstream Energy Fund Inc.
DSE
$41K ﹤0.01%
7,553
-1,907
-20% -$9.93K
BLCN
5584
DELISTED
Siren ETF Trust Siren NexGen Economy ETF
BLCN
$40K ﹤0.01%
1,436
+61
+4% +$1.54K
IPI icon
5585
Intrepid Potash
IPI
$456M
$40K ﹤0.01%
4,056
+1,933
+91% +$20.1K
MLP icon
5586
Maui Land & Pineapple Co
MLP
$344M
$40K ﹤0.01%
3,583
+1,561
+77% +$16.4K
SOYB icon
5587
Teucrium Soybean Fund
SOYB
$61M
$40K ﹤0.01%
2,837
+1,553
+121% +$21.3K
AIOT
5588
PowerFleet Inc
AIOT
$526M
$40K ﹤0.01%
8,715
+2,591
+42% +$12K
ALPN
5589
DELISTED
Alpine Immune Sciences Inc
ALPN
$40K ﹤0.01%
4,075
+4,068
+58,114% +$17.6K
ATLC icon
5590
Atlanticus Holdings
ATLC
$1.59B
$39K ﹤0.01%
3,769
+1,083
+40% +$14.4K
BLOK icon
5591
Amplify Blockchain Technology ETF
BLOK
$1.08B
$39K ﹤0.01%
1,952
GLL icon
5592
ProShares UltraShort Gold
GLL
$127M
$39K ﹤0.01%
273
-194
-42% -$30K
SHAG icon
5593
WisdomTree Yield Enhanced US Short-Term Aggregate Bond Fund
SHAG
$47.1M
$39K ﹤0.01%
760
-361
-32% -$18.4K
SRTS icon
5594
Sensus Healthcare
SRTS
$47.9M
$39K ﹤0.01%
12,695
VLT icon
5595
Invesco High Income Trust II
VLT
$64.9M
$39K ﹤0.01%
3,308
-1,435
-30% -$16.1K
VUZI icon
5596
Vuzix
VUZI
$194M
$39K ﹤0.01%
16,282
+1,818
+13% +$3.76K
ENZ
5597
DELISTED
Enzo Biochem, Inc.
ENZ
$39K ﹤0.01%
17,698
+10,509
+146% +$27K
SHSP
5598
DELISTED
SharpSpring, Inc.
SHSP
$39K ﹤0.01%
4,448
+2,645
+147% +$20.7K
ZCAN
5599
DELISTED
SPDR Solactive Canada ETF
ZCAN
$39K ﹤0.01%
730
BLPH
5600
DELISTED
Bellerophon Therapeutics, Inc.
BLPH
$39K ﹤0.01%
3,098
+465
+18% +$6.51K

Similar funds

Morgan Stanley's Q2 2020 Portfolio in Review

As of Q2 2020, Morgan Stanley held 6,941 positions worth $452B, up 23% from $368B the previous quarter. Its ten largest holdings account for 17% of the portfolio.

Morgan Stanley's Q2 2020 filing shows 185 new, 3,288 increased, 2,645 reduced and 222 closed positions. Its largest new stake was Royalty Pharma: 6,205,186 shares worth $301M. The largest sale was State Street SPDR S&P 500 ETF Trust, an estimated $5.07B.

By sector, the portfolio is most concentrated in Technology at 19% of assets, up from 16% a quarter earlier, followed by Healthcare and Consumer Discretionary.

  • Morgan Stanley's largest Q2 2020 buy was Royalty Pharma: 6,205,186 shares worth $301M.
  • Morgan Stanley added most to Block Inc in Q2 2020, an estimated $1.53B increase.
  • Morgan Stanley's biggest Q2 2020 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $5.07B.
  • Morgan Stanley fully exited Allergan plc in Q2 2020, selling an estimated $487M.
  • Morgan Stanley's ten largest holdings make up 17% of its $452B portfolio in Q2 2020.
  • Morgan Stanley opened 185 new positions and closed 222 in Q2 2020.
  • Morgan Stanley's portfolio value rose 23% quarter-over-quarter to $452B.

Based on Morgan Stanley's 13F filing for Q2 2020, filed 14 Aug 2020.